drugset / Trial / NCT01440608

Effectiveness of High-dose Zinc Therapy and Albendazole in the Treatment of Environmental Enteropathy

NCT01440608

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the therapeutic effectiveness of high-dose zinc therapy and de-worming albendazole as separate interventions in restoring normal gut absorptive and immunological function as measured by the dual sugar permeability test and additional biomarkers in 1-3 year old rural Malawian children at high risk for Environmental Enteropathy.

Timeline

Start
2011-10
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Albendazole Small molecule 200 mg Oral
Subject Albendazole Small molecule 400 mg Oral

Indications

No indication recorded.